Portal Biotech

Developer of biosensing technology that utilizes bioengineered nanopores to analyze proteins and metabolomics

placeLondon, England, United Kingdom calendar_todayFounded 2021 language portalbiotech.com

Registered entities

Social engagement

Social engagement: 4.4K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include NIF, Earlybird.

Investor typeCountShare
Venture capital975%
Private equity18%
Bank & private debt18%
Other / undisclosed18%

Recent activity

29 Jun 2026
Event
Groen Research Conferences on Single Molecule Approaches to Biology
22 Jun 2026
Event
7th International Metaproteomics Symposium
9 Jan 2026
Recognition
Coming soon